Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease - PubMed (original) (raw)
Comparative Study
. 2006 Feb;59(2):298-309.
doi: 10.1002/ana.20753.
Shin Hayashi, Matthew J Farrer, Andrew B Singleton, Hiroyo Yoshino, Hisamasa Imai, Toshiaki Kitami, Kenichi Sato, Ryu Kuroda, Hiroyuki Tomiyama, Koichi Mizoguchi, Miho Murata, Tatsushi Toda, Issei Imoto, Johji Inazawa, Yoshikuni Mizuno, Nobutaka Hattori
Affiliations
- PMID: 16358335
- DOI: 10.1002/ana.20753
Comparative Study
Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease
Kenya Nishioka et al. Ann Neurol. 2006 Feb.
Abstract
Objective: Recently, genomic multiplications of alpha-synuclein gene (SNCA) have been reported to cause hereditary early-onset parkinsonism. The objective of this study was to assess the frequency of SNCA multiplications among autosomal dominant hereditary Parkinson's disease (ADPD).
Methods: We screened 113 ADPD probands and 200 sporadic PD cases by quantitative polymerase chain reaction and confirmed SNCA multiplications by fluorescence in situ hybridization (FISH) and comparative genomic hybridization array.
Results: Two families (two patients from Family A and one from Family B) with SNCA duplication were identified among ADPD patients. Even though they had the same SNCA duplication, one patient had dementia. Because there was exactly the same difference between the regions originated from each patient, the finding suggests that the phenotype of SNCA multiplication may be also influenced by the range of duplication region. We also detected asymptomatic carriers in the families of both patients. Interestingly, the penetrance ratio was 33.3% (2/6) in one kindred, indicating that the ratio was very much lower than expected.
Interpretation: These two newly identified Japanese patients with SNCA duplication and the five previously identified American and European families with SNCA triplication or duplication mutations indicate that the incidence of SNCA multiplication may be more frequent than previously estimated.
Similar articles
- Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.
Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A, Bonnet AM, Brefel-Courbon C, Heath S, Zelenika D, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group. Ibáñez P, et al. Arch Neurol. 2009 Jan;66(1):102-8. doi: 10.1001/archneurol.2008.555. Arch Neurol. 2009. PMID: 19139307 - [Relationship between alpha-synuclein and Parkinson's disease].
Nishioka K, Hattori N. Nishioka K, et al. Brain Nerve. 2007 Aug;59(8):825-30. Brain Nerve. 2007. PMID: 17713118 Review. Japanese. - Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.
Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson EM, Schüle B, Langston JW, Middleton FA, Ross OA, Hulihan M, Gasser T, Farrer MJ. Fuchs J, et al. Neurology. 2007 Mar 20;68(12):916-22. doi: 10.1212/01.wnl.0000254458.17630.c5. Epub 2007 Jan 24. Neurology. 2007. PMID: 17251522 - Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.
Ikeuchi T, Kakita A, Shiga A, Kasuga K, Kaneko H, Tan CF, Idezuka J, Wakabayashi K, Onodera O, Iwatsubo T, Nishizawa M, Takahashi H, Ishikawa A. Ikeuchi T, et al. Arch Neurol. 2008 Apr;65(4):514-9. doi: 10.1001/archneur.65.4.514. Arch Neurol. 2008. PMID: 18413475 - Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL, Przedborski S, Petrucelli L. Eriksen JL, et al. Trends Mol Med. 2005 Mar;11(3):91-6. doi: 10.1016/j.molmed.2005.01.001. Trends Mol Med. 2005. PMID: 15760766 Review.
Cited by
- α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, Proukakis C, Quinn N, Lees AJ, Hardy J, Revesz T, Houlden H, Holton JL. Kiely AP, et al. Acta Neuropathol. 2013 May;125(5):753-69. doi: 10.1007/s00401-013-1096-7. Epub 2013 Feb 12. Acta Neuropathol. 2013. PMID: 23404372 Free PMC article. - The prion hypothesis of Parkinson's disease.
Chu Y, Kordower JH. Chu Y, et al. Curr Neurol Neurosci Rep. 2015 May;15(5):28. doi: 10.1007/s11910-015-0549-x. Curr Neurol Neurosci Rep. 2015. PMID: 25868519 - Gene therapy in Parkinson's disease: rationale and current status.
Feng LR, Maguire-Zeiss KA. Feng LR, et al. CNS Drugs. 2010 Mar;24(3):177-92. doi: 10.2165/11533740-000000000-00000. CNS Drugs. 2010. PMID: 20155994 Free PMC article. Review. - MicroRNA-7 Enhances Subventricular Zone Neurogenesis by Inhibiting NLRP3/Caspase-1 Axis in Adult Neural Stem Cells.
Fan Z, Lu M, Qiao C, Zhou Y, Ding JH, Hu G. Fan Z, et al. Mol Neurobiol. 2016 Dec;53(10):7057-7069. doi: 10.1007/s12035-015-9620-5. Epub 2015 Dec 16. Mol Neurobiol. 2016. PMID: 26676570 - Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy.
Paccosi E, Proietti-De-Santis L. Paccosi E, et al. Int J Mol Sci. 2023 May 31;24(11):9547. doi: 10.3390/ijms24119547. Int J Mol Sci. 2023. PMID: 37298496 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous